ATE431162T1 - Verfahren zur inaktivierung von viren durch trockene hitze - Google Patents

Verfahren zur inaktivierung von viren durch trockene hitze

Info

Publication number
ATE431162T1
ATE431162T1 AT06847095T AT06847095T ATE431162T1 AT E431162 T1 ATE431162 T1 AT E431162T1 AT 06847095 T AT06847095 T AT 06847095T AT 06847095 T AT06847095 T AT 06847095T AT E431162 T1 ATE431162 T1 AT E431162T1
Authority
AT
Austria
Prior art keywords
inactivation
viruses
dry heat
present
transition temperature
Prior art date
Application number
AT06847095T
Other languages
German (de)
English (en)
Inventor
Annie Bardat
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Application granted granted Critical
Publication of ATE431162T1 publication Critical patent/ATE431162T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT06847095T 2005-12-19 2006-12-19 Verfahren zur inaktivierung von viren durch trockene hitze ATE431162T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0512875A FR2894830B1 (fr) 2005-12-19 2005-12-19 Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse
PCT/FR2006/002817 WO2007071845A2 (fr) 2005-12-19 2006-12-19 Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse

Publications (1)

Publication Number Publication Date
ATE431162T1 true ATE431162T1 (de) 2009-05-15

Family

ID=36698885

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06847095T ATE431162T1 (de) 2005-12-19 2006-12-19 Verfahren zur inaktivierung von viren durch trockene hitze

Country Status (16)

Country Link
US (1) US8252227B2 (https=)
EP (1) EP1981549B1 (https=)
JP (1) JP5085558B2 (https=)
KR (1) KR101162060B1 (https=)
CN (1) CN101355972B (https=)
AT (1) ATE431162T1 (https=)
AU (1) AU2006328804B2 (https=)
BR (1) BRPI0621074B1 (https=)
CA (1) CA2633338C (https=)
DE (1) DE602006006875D1 (https=)
DK (1) DK1981549T3 (https=)
ES (1) ES2327279T3 (https=)
FR (1) FR2894830B1 (https=)
IL (1) IL192194A (https=)
PL (1) PL1981549T3 (https=)
WO (1) WO2007071845A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2811526T3 (es) 2010-12-30 2021-03-12 Lab Francais Du Fractionnement Glicoles como agentes de inactivación de patógenos
USD689039S1 (en) * 2012-07-12 2013-09-03 Alljack Co., Ltd. Stereo set
CN109444209A (zh) * 2018-10-26 2019-03-08 北京食品科学研究院 一种测量蛋清粉玻璃化转变温度的方法
CN116059410A (zh) * 2021-08-19 2023-05-05 南京金斯瑞生物科技有限公司 一种去除生物样本中噬菌体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2248817C2 (de) * 1972-10-05 1981-09-24 Bayer Ag, 5090 Leverkusen Polycarbonatmischungen
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
US5837519A (en) * 1996-11-21 1998-11-17 Bayer Corporation Dry-heat viral inactivation under controlled moisture conditions
EP1015571B1 (en) * 1997-09-23 2009-04-22 Ib2, L.L.C. Rapid thermal cycle processing methods and apparatus
CN1286725A (zh) * 1997-11-26 2001-03-07 环球保藏技术股份有限公司 敏感性生物样品的玻化保质法
DE69913186T3 (de) * 1998-10-14 2012-08-09 Katrina T. Forest Verfahren zur verglasung einer biologischen probe
EP1244352A4 (en) * 2000-01-04 2003-04-23 Univ Connecticut OVOCYTE VITRIFICATION TECHNIQUE
EP1651275A1 (en) * 2003-08-05 2006-05-03 Fuji Photo Film B.V. Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions

Also Published As

Publication number Publication date
CN101355972A (zh) 2009-01-28
ES2327279T3 (es) 2009-10-27
CA2633338C (en) 2012-02-28
BRPI0621074A2 (pt) 2011-11-29
IL192194A (en) 2010-12-30
AU2006328804A1 (en) 2007-06-28
KR101162060B1 (ko) 2012-07-03
DK1981549T3 (da) 2009-08-17
FR2894830B1 (fr) 2008-04-04
PL1981549T3 (pl) 2009-10-30
CN101355972B (zh) 2012-07-04
US8252227B2 (en) 2012-08-28
WO2007071845A2 (fr) 2007-06-28
WO2007071845A3 (fr) 2007-08-16
EP1981549B1 (fr) 2009-05-13
KR20080093098A (ko) 2008-10-20
JP2009519920A (ja) 2009-05-21
JP5085558B2 (ja) 2012-11-28
EP1981549A2 (fr) 2008-10-22
DE602006006875D1 (de) 2009-06-25
IL192194A0 (en) 2009-02-11
FR2894830A1 (fr) 2007-06-22
CA2633338A1 (en) 2007-06-28
US20090297398A1 (en) 2009-12-03
BRPI0621074B1 (pt) 2016-07-26
AU2006328804B2 (en) 2012-08-02

Similar Documents

Publication Publication Date Title
WO2008033466A3 (en) Compositions and methods for treatment of viral diseases
NZ598000A (en) Composition for treating hbv infection
ATE398672T1 (de) Immortalisierte vogelzellinien zur virusproduktion
DE602006019629D1 (de) Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
WO2010047830A3 (en) Agents for hcv treatment
EA201290152A1 (ru) Антисмысловые ингибиторы вируса гепатита в (hbv)
EA200870164A1 (ru) Лечение вирусного гепатита
NO20090447L (no) Hepatittt C virusinhibitorer
EA201391572A1 (ru) Модулирование экспрессии вируса гепатита в (hbv)
DK1749029T3 (da) Bindemolekyler, der kan neutralisere rabiesvirus, og anvendelser deraf
EA201000948A1 (ru) Ингибиторы вирусной полимеразы
NO20081087L (no) Fremgangsmater for fremstilling av sterilisert pankreatinpulver
EP1863941A4 (en) CHIMERIC INFECTIOUS VIRUSES OF HEPATITIS C, THEIR PRODUCTION METHODS AND METHODS OF USE
WO2010132604A3 (en) Neutralizing molecules to influenza viruses
ATE494291T1 (de) Verbindungen zur behandlung von hepatitis c
EE200800036A (et) Meetod kartuli viirushaigustest tervendamiseks ja parandatud omadustega meristeemkloonide loomiseks, viirusvaba kartuli meristeemtaim ning viirusvaba kartul
WO2009067191A3 (en) Methods and compositions for the treatment of hepatitis c virus (hcv) infection
EA201071086A1 (ru) Усовершенствованный способ получения вакцинных антигенов вируса гриппа
DE502006002836D1 (de) Verfahren zur herstellung von celluloseetherprodukten mit erhöhter viskosität und feinheit
IL192194A (en) Method of viral inactivation by dry heating
ATE505541T1 (de) Targeting von zwischenprodukten zur gegenstrangreplikation von einzelstrangigen viren durch rnai
UA96627C2 (ru) Сухой экстракт из pelargonium sidoides ta pelargonium reniforme, способ его получения и продукты на его основе
MY169510A (en) Detection of epstein -barr virus (ebv) in nasopharyngeal cancer
DE602006017011D1 (de) Verfahren zur Herstellung von Mannich Kondensationsprodukte zur Verwendung als Chelatbildner
EP3452595A4 (en) REAGENTS FOR THE TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTION AND USE THEREOF

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1981549

Country of ref document: EP